Share
16,315 Posts.
lightbulb Created with Sketch. 4369
clock Created with Sketch. 26/06/23
11:10
Share
Originally posted by TheAnalyst007:
↑
At the moment it's about US$50,000 per doctor per year. I suspect this should increase significantly as most doctors will likely increase their usage of the procedure now that it is much easier and efficient to use. It's recurring revenue (due to single use nature of the device) which will necessarily mean it will command a higher valuation multiple. Even more, the legacy device has proved that customer retention is very high so once the company has penetrated the market they should be able to significantly ease up on the marketing spend (boosting bottom line performance).
Expand
And of course, my thesis is that iTrack Advance is a superior device to alternatives (for reasons explained in previous posts) and should therefore take significant market share within that large market
(20min delay)